Here is the weekly recap of what you might have missed!
Patents
Rose Hughes explained cell therapies and their unique challenges in the pharmaceutical marketplace. She also provided insights regarding loss of exclusivity.
 |
Plant Varieties
Jocelyn Bosse reported on a recent decision of the Supreme People’s Court concerning compensation for the unauthorised plantings and sale of an apple variety called 'Scilate'. The Court awarded RMB 3.3 million (£319,000) in damages, recording the largest award for a civil claim for PVR infringement.
Copyright and AI
Eleonora Rosati reviewed the US Court of Appeal decision in A Recent Entrance to Paradise which is an artistic work that is claimed to have been entirely generated by Dr Stephen Thaler’s Creativity Machine. The Court of Appeal has confirmed that “the Copyright Act of 1976 requires all eligible work to be authored in the first instance by a human being.”
Trade Marks
Söğüt Atilla discussed the EUIPO Fifth Board of Appeal's decision to refuse to register a colour combination for “agricultural machines and implements, namely field sprayers” in Class 7 of the Nice Classification due to the absence of sufficient evidence demonstrating acquired distinctiveness through use under Article 7(3) EU Trade Mark Regulation.
Designs
Marcel Pemsel looked into the latest decision of the General Court concerning the design of a light bulb and the interpretation of Art. 7(2) Community Design Regulation.
IP events and opportunities
Oliver Fairhurst informed the Readers of upcoming events from Italy, the UK, Poland, and USA. Several opportunities include a Senior Research Associate recruitment from the Faculty of Law at the University of Cambridge. The Cambridge Faculty of Law is also recruiting a Senior Research Associate to work on the challenges of innovation and advanced medical computing. Be sure to check out our post and Events page for more details.
Never Too Late: If you missed the IPKat last week!
Reviewed by Asude Sena Moya
on
Tuesday, March 25, 2025
Rating:
Reviewed by Asude Sena Moya
on
Tuesday, March 25, 2025
Rating:
Follow the IPKat on LinkedIn 
Posts
No comments:
All comments must be moderated by a member of the IPKat team before they appear on the blog. Comments will not be allowed if the contravene the IPKat policy that readers' comments should not be obscene or defamatory; they should not consist of ad hominem attacks on members of the blog team or other comment-posters and they should make a constructive contribution to the discussion of the post on which they purport to comment.
It is also the IPKat policy that comments should not be made completely anonymously, and users should use a consistent name or pseudonym (which should not itself be defamatory or obscene, or that of another real person), either in the "identity" field, or at the beginning of the comment. Current practice is to, however, allow a limited number of comments that contravene this policy, provided that the comment has a high degree of relevance and the comment chain does not become too difficult to follow.
Learn more here: http://ipkitten.blogspot.com/p/want-to-complain.html